Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

P484: Gemtuzumab-based induction chemotherapy combined with midostaurin for FLT3 mutated AML. Updated toxicity and interim survival analysis from the NCRI AML19v2 "Midotarg" Pilot Trial

Russell, Nigel, Cumming, Oliver, Othman, Jad, Dillon, Richard, Potter, Nicola, Wilhelm-Benartzi, Charlotte ORCID: https://orcid.org/0000-0003-4927-6158, Jovanovic, Jelena, Gilkes, Amanda, Batten, Leona, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Laura Hinson, Emily, Kottaridis, Panagiotis, Cavenagh, Jamie, Arnold, Claire, Dennis, Mike and Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441 2023. P484: Gemtuzumab-based induction chemotherapy combined with midostaurin for FLT3 mutated AML. Updated toxicity and interim survival analysis from the NCRI AML19v2 "Midotarg" Pilot Trial. HemaSphere 7 (S3) , e13145db. 10.1097/01.HS9.0000968844.13145.db

[thumbnail of p484__gemtuzumab_based_induction_chemotherapy.385.pdf] PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (981kB)
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Centre for Trials Research (CNTRR)
Publisher: Wiley Open Access
ISSN: 2572-9241
Date of First Compliant Deposit: 25 June 2024
Last Modified: 25 Jun 2024 13:02
URI: https://orca.cardiff.ac.uk/id/eprint/168390

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics